Fig. 1

Best response by Response Evaluation Criteria in Solid Tumor (RECIST), measured as maximum percent change of tumor RECIST measurements from baseline. Tumor type (and cohort) are denoted below each bar. Green denotes partial response, yellow denotes stable disease, and red denotes progressive disease. A, alternate dose schedule; CER, cervical; EM, endometrial; ESO, esophageal; MESO, mesothelial; OV, ovarian/fallopian/peritoneal; URE, urethral; VA, vaginal